Abstract
Despite the urgency of the problem of prevention and treatment of neurodegenerative processes underlying Alzheimer's disease (AD) and other severe disorders of the central nervous system, therapeutic and prophylactic potential of drugs is yet insufficient. Numerous adverse effects of the drugs, which might improve cognitive function in patients with AD substantiate serious consideration of measures enhancing adaptive potential and mobilizing self-defense of the body. It is clear now that endogenous defense systems of the brain can limit progression of AD long after the onset of the disease. The measures mobilizing the self-defense include administration of natural adaptogens and various types of adaptation, such as adaptation to dietary restrictions, promotion of physical and mental activity, and adaptation to hypoxia. This review presents data supporting a hypothesis that non-drug activation of self-defense of the body can prevent cognitive decline induced by neurodegenerative processes in the brain by targeting key points of AD pathogenesis.
Similar content being viewed by others
REFERENCES
Abraham, I., Harkany, T., Horvath, K.M., Veenema, A.H., Penke, B., Nyakas, C., and Luiten, P.G., Chronic Corticosterone Administration Dose-Dependently Modulates Abeta(1-42)-and NMDA-Induced Neurodegeneration in Rat Magnocellular Nucleus Basalis, J. Neuroendocrinol., 2000, vol. 12, pp. 486–494.
Addae, J.I., Youssef, F.F., and Stone, T.W., Neuroprotective Role of Learning in Dementia: A Biological Explanation, J. Alzheimer's Dis., 2003, vol. 5, pp. 91–104.
Ahlemeyer, B. and Krieglstein, J., Pharmacological Studies Supporting the Therapeutic Use of Ginkgo bilobaExtract for Alzheimer's Disease, Pharmacopsychiatry, 2003, vol. 36, pp. S8–S14.
Ashkenazi, A. and Dixit, V.M., Death Receptors: Signaling and Modulation, Science, 1998, vol. 281, pp. 1305–1308.
Bachurin, S.O., Medical Chemistry of Directed Drug Search for Prevention and Treatment of Neurodegenerative Disorders at the Example of Alzheimer's Disease, Neirodegenerativnye bolezni i starenie (Neurodegenerative Disorders and Aging), Zavalishin, I.A., Yakhno, N.N., and Gavrilov, S.I., Eds., Moscow, 2001, pp. 399–454.
Ball, L.J. and Birge, S.J., Prevention of Brain Aging and Dementia, Clin. Geriatr. Med., 2002, vol. 18, pp. 485–503.
Belykh, A.G., Gukasov, V.M., and Chukaev, S.A., State of the Free-Radical Oxidation System in Normobaric Hypoxia, Fiziol. Zh., 1992, vol. 38, pp. 73–76.
Berghmans, R.L., Anti-Alzheimer Drugs: Ethical Aspects of Research and Practice, Tijdschr. Gerontol. Geriatr., 2000, vol. 31, pp. 100–106.
Bohme, G.A., Bon, C., Stutzmann, J.-M., Doble, A., and Blanchard, J.-C., Possible Involvement of Nitric Oxide in Long-Term Potentiation, Eur. J. Pharmacol., 1991, vol. 199, pp. 379–381.
Boyer, M., Townsend, L.E., Vogel, L., Falk, J., Reitz-Vick, D., and Trevor, K., Isolation of Endothelial Cells from Human Peripheral Blood, J. Vasc. Surg.,2000, vol. 31, pp. 181–189.
Brown, I.R. and Gozes, I., Stress Genes in the Nervous System during Development and Aging Diseases, Ann. New York Acad. Sci., 1998, vol. 851, pp. 123–128.
Butterfield, K.A., Howard, B., Yatin, S., Koppal, T., Drake, J., Hensley, K., Aksenov, M., Aksenova, M., Subramaniam, R., Varadarajan, S., Harris-White, M.E., Pedigo, N.M., Jr., and Carmey, J.M., Elevated Oxidative Stress in Models of Human Brain Aging and Alzheimer's Disease, Life Sci.,1999, vol. 65, pp. 1883–1892.
Calabrese, V., Bates, T.E., and Stella, A.M., NO Synthase and NO-Dependent Signal Pathways in Brain Aging and Neurodegenerative Disorders: the Role of Oxidant/Antioxidant Balance, Neurochem. Res.,2000, vol. 25, pp. 1315–1341.
Cande, C., Cohen, I., Daugas, E., Ravagnan, L., Larochette, N., Zamzami, N., and Kroemer, G., Apoptosis-Inducing Factor (AIF): A Novel Caspase-Independent Death Effector Released from Mitochondria, Biochimie, 2002, vol. 84, pp.215-122.
Cardinali, D.P., Brusco, L.I., Liberczuk, C., and Furio, A.M., The Use of Melatonin in Alzheimer's Disease, Neuroendocrinol.Lett., 2002, vol. 23, ppl. 1, pp. 20–23.
Celermajer, D.S., Endothelial Dysfunction: Does It Matter? Is It Reversible?, J. Am. Coll. Cardiol., 1997, vol. 30, pp. 325–353.
Chabrier, P.-E., Demerle-Pallardy, C., and Auguet, M., Nitric Oxide Synthases: Targets for Therapeutic Strategies in Neurological Diseases, Cell Mol. Life Sci., 1999, vol. 55, pp. 1029–1035.
Christen, Y., Oxidative Stress and Alzheimer Disease, AmJ. Clin. Nutr., 2000, vol. 71, pp. 621S–629S.
Clippingdale, A.B., Wade, J.D., and Barrow, C.J., The Amyloid-Beta Peptide and Its Role in Alzheimer's Disease, J. Pept. Sci., 2001, vol. 7, pp. 227–249.
Colasanti, M. and Suzuki, H., The Dual Personality of NO, Trends Pharmacol. Sci., 2000, vol. 21, pp. 249–252.
D'Andrea, M.R., Nagele, R.G., Wang, H.Y., Peterson, P.A., and Lee, D.H., Evidence That Neurons Accumulating Amyloid Can Undergo Lysis to Form Amyloid Plaques in Alzheimer's Disease, Histopathology., 2001, vol. 38, p. 120–134.
Datta, P.K. and Lianos, E.A., Nitric Oxide Induces Heme Oxygenase-1 Gene Expression in Mesangial Cells, Kidney International, 1999, vol. 55, pp. 1734–1739.
De la Torre, J.C., Alzheimer's Disease: How Does It Start?, J. Alzheimer's Dis.,2002, vol. 4, pp. 497–512.
De la Torre, J.C. and Stefano, G.B., Evidence that Alzheimer's Disease Is a Microvascular Disorder: The Role of Constitutive Nitric Oxide, Brain Res. Rev., 2000, vol. 34, pp. 119–136.
Dodd, P.R., Excited to Death: Different Ways To Lose Your Neurons, Biogerontology,2002, vol. 3, pp. 51–56.
Dou, F., Netzer, W.J., Tanemura, K., Li, F., Hartl, F.U., Takashima, A., Gouras, G.K., Greengard, P., and Xu, H.,Chaperones Increase Association of Tau Protein with Microtubules, Proc. Natl. Acad. Sci. USA.,2003, vol. 100, pp. 721–726.
Dykens, J.A., Isolated Cerebral and Cerebellar Mitochondria Produce Free Radicals When Exposed to Elevated Ca2+ and Na+: Implication for Neurodegeneration, J. Neurochem., 1994, vol. 63, pp. 584–591.
El'chaninova, S.A., Korenyak, N.A., Smagina, I.V., Pinegin, L.E., and Varshavskii, B.Ya., Intermittent Hypoxia in the Treatment of Dyscirculatory Encephalopathy, Zh. Nevrol.Psikhiatr. Im. S.S. Korsakova, 2002, vol. 102, pp. 29–32.
Fonte, V., Kapulkin, V., Taft, A., Fluet, A., Friedman, D., and Christopher, D., Interaction of Intracellular ??Amyloid Peptide with Chaperone Proteins, Proc. Natl. Acad. Sci. USA, 2002, vol. 99, pp. 9439–9444.
Gabai, V.L., Meriin, A.B., Yaglom, J.A., Volloch, V.Z., and Sherman, M.Y., Role of Hsp70 in Regulation of Stress-Kinase JNK: Implications in Apoptosis and Aging, FEBS Lett., 1998, vol. 438, pp. 1–4.
Getchell, T.V., Krishna, N.S., Dhooper, N., Sparks, D.L., and Getchell, M.L., Human Olfactory Receptor Neurons Express Heat Shock Protein 70: Age-Related Trends, Ann. Otol. Rhinol.Laryngol., 1995, vol. 104, pp. 47–50.
Ghosh, C. and Lahiri, D.K., Increased Vulnerability of Neuronal Cell Lines to Sodium Nitroprusside-Mediated Toxicity Is Caused by the Decreased Level of Nitric Oxide Metabolites, J. Mol. Neurosci., 1999, vol. 13, pp. 77–92.
Gielen, S., Schuler, G., and Hambrecht, R., Exercise Training in Coronary Artery Disease and Coronary Vasomotion, Circulation., 2001, vol. 103, pp. E1–E6.
Gouras, G.K., Tsai, J., Naslund, J., Vincent, B., Edgar, M., Checler, F., Greenfield, J.P., Haroutunian, V., Buxbaum, J.D., Xu, H., Greengard, P., and Relkin, N.R., Intraneuronal Abeta42 Accumulation in Human Brain, Am. J. Pathol., 2000, vol. 156, pp. 15–20.
Grundman, M., Grundman, M., and Delaney, P., Antioxidant Strategies for Alzheimer's Disease, Proc. Nutr. Soc., 2002, vol. 61, pp. 191–202.
Gulyaeva, N.V., Stepanichev, M.V., Onifriev, M.V., Sergeev, I.V., Mitrokhina, O.S., Moiseeva, Yu.V., and Tkatchouk, E.N., Interval Hypoxia Training Prevents Oxidative Stress in Striatum and Locomotor Disturbances in a Rat Model of Parkinsonism, Progress in Alzheimer's and Parkinson's Diseases, Fisher, A., Hanln, I., and Yoshida, M., Eds., New York: Plenum, 1998, pp. 717–723.
Hampl, V., Cornfield, D.N., Cowan, N.J., and Archer, S.L.,Hypoxia Potentiates Nitric Oxide Synthesis and Transiently Increases Cytosolic Calcium Level in Pulmonary Artery Endothelial Cells, Eur. Resp. J., 1995, vol. 8, pp. 515–522.
Hauss-Wegrzyniak, B., Dobrzanski, P., Stoehr, J.D., and Wenk, G.L., Chronic Inflammation in Rats Reproduces Components of the Neurobiology of Alzheimer's Disease, Brain Res., 1998, vol. 780, pp. 294–303.
Heininger, K., A Unifying Hypothesis of Alzheimer's Disease.IV. Causation and Sequence of Events, Rev. Neurosci., 2000, vol. 11, pp. 213–328.
Hu, J., Akama, K.T., Kraff, G.A., Chromy, B.A., and Eldik, L.J., Amyloid-Beta Peptide Activates Cultured Astrocytes: Morphological Alterations, Cytokine Induction and Nitric Oxide Release, Brain Res.,1998, vol. 785, pp. 195–206.
Johnson, G., Refolo, L.M., and Wallace, W., Heat-Shocked Neuronal PC12 Cells Reveal Alzheimer's Disease-Associated Alterations in Amyloid Precursor Protein and Tau, Ann New York. Acad. Sci., 1993, vol. 695, pp. 194–197.
Kakimura, J., Kitamura, Y., Takata, K., Umeki, M., Suzuki, S., Shibagaki, K., Taniguchi, T., Nomura, Y., Gebicke-Haerter, P.J., Smith, M.A., Perry, G., and Shimohama, S., Microglial Activation and Amyloid-Beta Clearance Induced by Exogenous Heat-Shock Proteins, FASEB J., 2002, vol. 16, pp. 601–603.
Kaur, C., Srinivasan, K.N., Singh, J., Peng, C.M., and Ling, E.A., Plasma Melatonin, Pinealocyte Morphology, and Surface Receptors/Antigen Expression on Macrophages/ Microglia in the Pineal Gland Following a High-Altitude Exposure, J. Neurosci. Res., 2002, vol. 67, pp. 533–543.
Kim, Y.-M., Bergonia, H.A., Muller, C., Pitt, B.R., Watkins, W.D., and Lancaster, J.R., Loss and Degradation of Enzyme Bound Heme Induced by Cellular Nitric Oxide Synthesis, J. Biol. Chem., 1995, vol. 270, pp. 5710–5713.
Kirby, B.A., Merril, C.R., Ghanbari, H., and Wallace, W.C., Heat Shock Proteins Protect against Stress-Related Phosphorylation of Tau in Neuronal PC12 Cells That Have Acquired Thermotolerance, J. Neurosci.,1994, vol. 14, pp. 5687–5693.
Klein, S.D. and Brune, B., Heat-Shock Protein 70 Attenuates Nitric Oxide-Induced Apoptosis in RAW Macrophages by Preventing Cytochrome C Release, Biochem. J., 2002, vol. 362, pp. 635–641.
Kluck, R.M., Bossy-Wetzel, E., Green, D.R., and Newmeyer, D.D., Mitochondrial Control of Apoptosis: the Role of Cytochrome c, Science, 1997, vol. 275, pp. 1132–1143.
Kontush, A., Amyloid-Beta: An Antioxidant That Becomes a Pro-Oxidant and Critically Contributes to Alzheimer's Disease, Free Radic. Biol. Med., 2001, vol. 31, pp. 1120–1131.
Kubes, P., Kanwar, S., and Niu, X.F., Nitric Oxide Synthesis Inhibition Induces Leukocyte Adhesion via Superoxide and Must Cells, FASEB J., 1993, vol. 7, pp. 1293–1299.
Kudva, Y.C., Hiddinga, H.J., Butler, P.C., Mueske, C.S., and Eberhardt, N.L., Small Heat Shock Proteins Inhibit in vitroA Beta(1-42) Amyloidogenesis, FEBS Lett., 1997, vol. 416, pp. 117–121.
Kumar-Singh, S., Dewachter, I., Moechars, D., Lubke, U., Jonghe, C., Ceuterick, C., Checler, F., Naidu, A., Cordell, B., Cras, P., Broeckhoven, C., and Leuven, F., Behavioral Disturbances without Amyloid Deposits in Mice Overexpressing Human Amyloid Precursor Protein with Flemish (A692G) or Dutch (E693Q) Mutation, Neurobiol. Dis., 2000, vol. 7, pp. 9–22.
LaManna, J.C., Vendel, L.M., and Farrell, R.M., Brain Adaptation to Chronic Hypobaric Hypoxia in Rats, J. Appl. Physiol., 1992, vol. 72, pp. 2238–2243.
Laurin, D., Verreault, R., and Lindsay, J., MacPherson K., and Rockwood, K., Physical Activity and Risk of Cognitive Impairment and Dementia in Elderly Persons, Arch. Neurol., 2001, vol. 58, pp. 498–504.
Law, A., Gauther, S., and Quirion, R.Say, NO to Alzheimer's Disease: The Putative Link between Nitric Oxide and Dementia of the Alzheimer's Type, Brain Res. Rev.,2001, vol. 35, pp. 73–96.
Lederman, R.J., Mendelson, F.O., Anderson, R.D., Saucedo, J., Tenaglia, A., and Hermiller, J., Therapeutic Angiogenesis with Recombinant Fibroblast Growth Factor-2 for Intermittent Claudication (the TRAFFIC Study): A Randomized Trial, Lancet, 2002, vol. 359, pp.2948-2050.
Losordo, D.W., Vale, P.R., Symes, J.F., Dunnington, C., and Esakof, D., Gene Therapy for Myocardial Angiogenesis: Initial Clinical Results with Direct Myocardial Injection of PhVEGF165 as Sole Therapy for Myocardial Ischemia, Circulation, 1998, vol. 98, pp. 2800–2804.
Mahendra, N. and Arkin, S., Effects of Four Years of Exercise, Language, and Social Interventions on Alzheimer Discourse, J. Commun. Disord., 2003, vol. 36, pp. 395–422.
Malyshev, I.Yu. and Manukhina, E.B., Stress, Adaptation and Nitric Oxide, Adaptation Biology and Medicine,Pandolf, B.B., Takeda, N., and Singal, P.K., Eds., New Delhi: Narosa, 1999, vol. 2, pp. 375–392.
Malyshev, I.Yu., Manukhina, E.B., Mikoyan, V.D., Kubrina, L.N., and Vanin, A.F., Nitric Oxide Is Involved in Heat-Induced HSP70 Accumulation, FEBS Lett., 1995, vol. 370, pp. 159–162.
Malyshev, I.Yu., Malugin, A.V., Golubeva, L.Yu., Zenina, T.A., Manukhina, E.B., Mikoyan, V.D., and Vanin, A.F., Nitric Oxide Donor Induces HSP70 Accumulation in the Heart and in Cultured Cells, FEBS Lett., 1996, vol. 391, pp. 21–23.
Malyshev, I.Yu., Zenina, T.A., Golubeva, L.Yu., Saltykova, V.A., Manukhina, E.B., Mikoyan, V.D., Kubrina, L.N., and Vanin, A.F., NO-Dependent Mechanisms of Adaptation to Hypoxia, Nitric Oxide, 1999, vol. 3, pp. 105–113.
Manukhina, E.B. and Malyshev, I.Yu., Stress-Limiting Nitric Oxide System, Ross. Fiziol. Zh. im. I M Sechenova, 2000, vol. 86, no. 10, pp. 1283–1292.
Manukhina, E.B. and Malyshev, I.Yu., Role of Nitric Oxide in Protective Effects of Adaptation, Adaptation Biology and Medicine, Moravec, J., Takeda, N., and Singal, P.K, Eds., New Delhi: Narosa, 2002, vol. 3, pp. 312–327.
Manukhina, E.B., Sokolova, I.A., and Rodionov, I.M., Changes in Vascular Network Density in the Brain Cortex of Rats with Experimental Hypertension and Adaptation to Hypoxia, Kardiologiya, 1982, no. 10, pp. 118–119.
Manukhina, E.B., Malyshev, I.Yu., Smirin, B.V., Mashina, S.Yu., Saltykova, V.A., and Vanin, A.F., Production and Storage of Nitric Oxide in Adaptation to Hypoxia, Nitric Oxide, 1999, vol. 3, pp. 393–401.
Manukhina, E.B., Mashina, S.Yu., Smirin, B.V., Lyamina, N.P., Senchikhin, V.N., Vanin, A.F., and Malyshev, I.Yu., Role of Nitric Oxide in Adaptation To Hypoxia and Adaptive Defense, Physiol. Res.,2000, vol. 49, pp. 89–97.
Manukhina, E.B., Smirin, B.V., Malyshev, I.Yu., Stokle, Zh.-K., Myuller, B., Solodkov, A.P., Shebeko, V.I., and Vanin, A.F., Nitric Oxide Storage in the Cardiovascular System, Izv. Acad. Nauk, Ser. Biol., 2002, no. 5, pp. 585–596.
Mark, R.J., Hensley, D.A., Butterfield, D.A., and Mattson, M.P., Amyloid Beta-Peptide Impairs Ion-Motive ATPase Activities: Evidence for a Role in Loss of Neuronal Ca2+ Homeostasis and Cell Death, J. Neurosci., 1995, vol. 15, pp. 6239–6249.
Mattson, M.P., Neuroprotective Signaling and the Aging Brain: Take away My Food and Let Me Run, Brain Res., 2000, vol. 886, pp. 47–53.
McCarty, M.F., Vascular Nitric Oxide May Lessen Alzheimer'sRisk, Med. Hypotheses,1998, vol. 51, pp. 465–476.
McDonnell, J., Redekop, W.K., Roer, N., Goes, E., Ruitenberg, A., Busschbach, J.J., Breteler, M.M., and Rutten, F.F., The Cost of Treatment of Alzheimer's Disease in the Netherlands: A Regression-Based Simulation Model, Pharmacoeconomics, 2001, vol. 19, pp. 379–390.
McGeer, E.G. and McGeer, P.L., Inflammatory Cytokines in the CNS, CNS Drugs., 1997, vol. 7, pp. 214–287.
Meerson, F.Z., Adaptation, Stress, and Prophylaxis,Berlin: Springer-Verlag, 1984.
Meerson, F.Z., Adaptatsionnaya Meditsina: Mekhanizmy I Zashchitnye Effekty Adaptatsii(Adaptive Medicine: Mechanisms and Protective Effects of Adaptation), Moscow: Hypoxia Medical, 1993.
Meerson, F.Z., Arkhipenko, Yu.V., Rozhitskaya, I.I., Didenko, V.V., and Sazontova, T.G., Opposite Effects of Adaptation to Continuous and Intermittent Hypoxia on Antioxidant Enzymes, Byul. Eksper. Biol. Med., 1992a, vol. 114,pp. 14–15.
Meerson, F.Z., Malyshev, I.Yu., and Zamotrinsky, A.V., Differences in the Development of the Phenomenon of Adaptive Stabilization of Structures during Adaptation To Stress and Adaptation To Hypoxia Are Related with the Differential Accumulation of Hsp70 Isoforms, Mol. Cell. Biochem., 1992b, vol. 111, pp. 87–95.
Meerson, F.Z., Pinelis, V.G., Koshelev, V.B., Golubeva, L.Yu., Ryasina, T.V., Arsen'eva, N., Krushinskii, A.L., and Storozhevykh, T.P., Adaptation to Periodic Hypoxia Restricts Subdural Hemorrhages in Audiogenic Epileptiform Convulsions in Rats, Biull. Eksp. Biol. Med., 1993, vol. 116, pp. 572–574.
De la Monte, S.M., Lu, B.X., Sohn, Y.K., Etienne, D., Kraft, J., Ganju, N., and Wands, J.R., Aberrant Expression of Nitric Oxide Synthase III in Alzheimer's Disease: Relevance to Cerebral Vasculopathy and Neurodegeneration, Neurobiol.Aging, 2000, vol. 21, pp. 309–319.
Mueller, X.M., Tevaearai, H., Chaubert, P., Genton, C.Y., and Sergesser, L., Mechanism of Action of Transmyocardial Revascularization, Schweiz. Med. Wochenschr.,1999, vol. 129, pp. 1889–1892.
Neubauer, J.A., Physiological and Pathophysiological Responses to Intermittent Hypoxia, J. Appl. Physiol., 2001, vol. 90, pp. 1593–1599.
Ohtsuka, K. and Suzuki, T., Roles of Molecular Chaperones in the Nervous System, Brain Res. Bull., 2000, vol. 53, pp. 141–146.
Omata, N., Murata, T., Takamatsu, S., Maruoka, N., Wada, Y., Yonekura, Y., and Fujibayashi, Y., Hypoxic Tolerance Induction in Rat Brain Slices Following Hypoxic Preconditioning Due to Expression of Neuroprotective Proteins as Revealed by Dynamic Changes in Glucose Metabolism, Neurosci. Lett., 2002, vol. 329, pp. 205–208.
Papadopoulos, M.C., Sun, X.Y., Cao, J., Mivechi, N.F., and Giffard, R.G., Over-Expression of HSP-70 Protects Astrocytes from Combined Oxygen-Glucose Deprivation, Neuroreport.,1996, vol. 7, pp. 429–432.
Pappolla, M.A., Chyan, Y.J., Poeggeler, B., Frangione, B., Wilson, G., Ghiso, J., and Reiter, R.J., An Assessment of the Antioxidant and the Antiamyloidogenic Properties of Melatonin: Implications for Alzheimer's Disease, J. Neural Transm., 2000, vol. 107, pp. 203–231.
Pappolla, M.A., Sos, M., Omar, R.A., and Sambamurti, K., The Heat Shock / Oxidative Stress Connection. Relevance to Alzheimer's Disease, Mol. Chem. Neuropathol.,1996, vol. 28, pp. 21–34.
Patt, S., Sampaolo, S., Theallier-Janko, A., Tschairkin, I., and Cervos-Navarro, J., Cerebral Angiogenesis Triggered by Severe Chronic Hypoxia Displays Regional Differences, J. Cereb. Blood Flow Metab.,1997, vol. 17, pp. 801–806.
Pecher, P. and Schumacher, B.A., Angiogenesis in Ischemic Human Myocardium: Clinical Results After 3 Years, Ann. Thorac. Surg., 2000, vol. 69, pp. 1414–1419.
Pedraza-Chaverri, J., Tapia, E., Medina-Campos, O.N., de los Angeles Granados, M., and Franco. M., Garlic Prevents Hypertension Induced by Chronic Inhibition of Nitric Oxide Synthesis, Life Sci.,1998, vol. 62, pp. PL71–PL77.
Pshennikova, M.G., Manukhina, E.B., Sazontova, T.G., Prodius, P.A., Golantsova, N.E., and Malyshev, I.Yu., Molecular Mechanisms of Adaptation To Environmental Factors: New Achievements of the Meerson School, Adaptation Biology and Medicine,Pandolf, B.B., Takeda, N., and Singal, P.K., Eds., New Delhi: Narosa, 1999, vol. 2, pp. 199–213.
Ravagnan, L., Gurbuxani, S., Susin, S.A., Maisse, C., Daugas, E., Zamzami, N., Mak, T., Jaattela, M., Penninger, J.M., Garrido, C., and Kroemer, G., Heat-Shock Protein 70 Antagonizes Apoptosis-Inducing Factor, Nat. Cell Biol., 2001, vol. 3, pp. 839–843.
Rayevsky, K.S., Bondarenko, N.A., Kudrin, V.S., and Miroshnichenko, I.I., Cognitive Deficiency Induced by the Acute Stress in Rats: A Possible Role of Brain Catecholaminergic Systems, Ann. Ist. Super Sanita., 1990, vol. 26, pp. 25–29.
Reiter, R.J., Cabrera, J., Sainz, R.M., Mayo, J.C., Manchester, L.C., and Tan, D.X., Melatonin as a Pharmacological Agent against Neuronal Loss in Experimental Models of Huntington's Disease, Alzheimer's Disease and Parkinsonism, Ann. New York Acad. Sci., 1999, vol. 890, pp. 471–485.
Renkawek, K., Bosman, G.J., and Gaestel, M., Increased Expression of Heat-Shock Protein 27 KDa in Alzheimer Disease: A Preliminary Study, Neuroreport.,1993, vol. 5, pp. 14–16.
Sadik, K. and Wilcock, G., The Increasing Burden of Alzheimer Disease, Alzheimer Dis. Assoc. Disord., 2003, vol. 17, pp. S75–S79.
Sasaki, A., Yamaguchi, H., Ogawa, A., Sugihara, S., and Nakazato, Y., Microglial Activation in Early Stages of Amyloid Beta Protein Deposition, Acta Neuropathol. ( Berl. ),1997, vol. 94, pp. 316–322.
Sazontova, T.G., Arkhipenko, Yu.V., and Meerson, F.Z., Adaptation to Periodic Hypoxia and Diet with omega-3 Polyunsaturated Fatty Acids Increases the Stability of Myocardial Sarcoplasmic Reticulum Ca2+ Transport to Free Radical Oxidation, Biull. Eks. Biol. Med.,1995, vol. 120, pp. 42–45.
Schulze-Osthoff, K., Ferrari, D., Los, M., Wesselborg, S., and Peter, M.E., Apoptosis Signaling by Death Receptors, Eur. J. Biochem., 1998, vol. 254, pp. 439–459.
Schumacher, B., Pecher, P., von Specht, B., and Stegman, T., Induction of Neogenesis in Ischemic Myocardium by Human Growth Factors, Circulation,1998, vol. 97, pp. 645–650.
Shanavas, A. and Papasozomenos, S.Ch., Tau Kinases in the Rat Heat Shock Model: Possible Implications for Alzheimer Disease, Proc. Natl. Acad. Sci. USA, 2000, vol. 97, pp. 14139–14144.
Soucek, T., Cumming, R., Dargusch, R., Maher, P., and Schubert, D., The Regulation of Glucose Metabolism by HIF-1 Mediates a Neuroprotective Response to Amyloid Beta Peptide, Neuron,2003, vol. 39, pp. 43–56.
Sun, X., Cole, G.M., Chu, T., Xia, W., Galasko, D., Yamaguchi, H., Tanemura, K., Frautschy, S.A., and Takashima, A., Intracellular Abeta Is Increased by Okadaic Acid Exposure in Transfected Neuronal and Non-Neuronal Cell Lines, Neurobiol Aging, 2002, vol. 23, pp. 195–203.
Swaab, D.F., Dubelaar, E.J., Scherder, E.J., van Someren, E.J., and Verwer, R.W., Therapeutic Strategies for Alzheimer Disease: Focus on Neuronal Reactivation of Metabolically Impaired Neurons, Alzheimer Dis. Assoc. Disord., 2003, vol. 17, pp. S114–S122.
Takahashi, K., Hara, E., Suzuki, H., Sasano, H., and Shibahara, S., Expression of Heme Oxygenase Isozyme mRNAs in the Human Brains and Induction of Heme Oxygenase-1 by Nitric Oxide Donors, J. Neurochem.,1996, vol. 67, pp. 482–489.
Tarkowski, E., Ringqvist, A., Blennow, K., Wallin, A., and Wennmalm, A., Intrathecal Release of Nitric Oxide in Alzheimer's Disease and Vascular Dementia, Dement. Geriatr.Cogn. Disord., 2000, vol. 11, pp. 322–326.
Teri, L., Gibbons, L.E., McCurry, S.M., Logsdon, R.G., Buchner, D.M., Barlow, W.E., Kukull, W.A., LaCroix, A.Z., McCormick, W., and Larson, E.B., Exercise plus Behavioral Management in Patients with Alzheimer Disease: A Randomized Controlled Trial, JAMA,2003, vol. 290, pp. 2015–2022.
Tsurumi Y., Takeshita S., Chen D., Keaney M., Rossow S. Direct Intramuscular Gene Transfer of Naked DNA Encoding Vascular Endothelial Growth Factor Augments Collateral Development and Tissue Perfusion, Cirulation, 1996, vol. 94, pp. 3281–3290.
Van Dongen, M.C., van Rossum, E., Kessels, A.G., Sielhorst, H.J., and Knipschild, P.G., The Efficacy of Ginkgofor Elderly People with Dementia and Age-Associated Memory Impairment: New Results of a Randomized Clinical Trial, J. Am. Geriatr. Soc., 2000, vol. 48, pp. 1183–1194.
Van der Zee, E.A., Douma, B.R., Bohus, B., and Luiten, P.G., Passive Avoidance Training Induces Enhanced Levels of Immunoreactivity for Muscarinic Acetylcholine Receptor and Coexpressed PKC Gamma and MAP-2 in Rat Cortical Neurons, Cereb. Cortex., 1994, vol. 4, pp. 376–390.
Vanin, A.F., Dinitrosyl Iron Complexes and S-Nitrosothiols Are Two Possible Forms for Stabilization and Transport of Nitric Oxide in Biological Systems, Biokhimiya,1998, vol. 63, no. 7, pp. 924–938.
Vincent, S.R. and Kimura, H., Histochemical Mapping of Nitric Oxide Synthase in the Rat Brain, Neuroscience, 1992, vol. 46, pp. 755–784.
Wakutani, Y., Urakami, K., Shimomura, T., and Takahashi, K., Heat Shock Protein 70 mRNA Levels in Mononuclear Blood Cells from Patients with Dementia of the Alzheimer Type, Dementia,1995, vol. 6, pp. 301–305.
Wenger, R.H. and Gassmann, M., Oxygen(es) and the Hypoxia-inducible Factor-1, Biol. Chem.,1997, vol. 378, pp. 609–616.
Willis, D., Tomlinson, A., Frederick, R., and Paul-Clark, M.J., Modulation of Heme Oxygenase Activity and Rat Brain and Spleen by Inhibitors and Donors of Nitric Oxide, Biochem. Biophys. Res. Commun., 1995, vol. 214, pp. 1152–1156.
Wirths, O., Multhaup, G., Czech, C., Blanchard, V., Moussaoui, S., Tremp, G., Pradier, L., Beyreuther, K., and Bayer, T.A., Intraneuronal Abeta Accumulation Precedes Plaque Formation in Beta-Amyloid Precursor Protein and Presenilin-1 Double-Transgenic Mice, Neurosci. Lett., 2001, vol. 306, pp. 116–120.
Wissink, M.J., Beernink, R., Poot, A.A., Engbers, G., and Beugeling, T., Improved Endothelization of Vascular Grafts by Local Release of Growth Factors from Heparinized Collagen Matrices, J. Contr. Rel., 2000, vol. 64, pp. 103–114.
Yan, S.D., Fu, J., Soto, C., Chen, X., Zhu, H., Al-Mohanna, F., Collison, K., Zhu, A., Stern, E., Saido, T., Tohyama, M., Ogawa, S., Roher, A., and Stern, D., An Intracellular Protein that Binds Amyloid-beta Peptide and Mediates Neurotoxicity in Alzheimer's Disease, Nature, 1997, vol. 389, pp. 689–695.
Yang, A.J., Chandswangbhuvana, D., Margol, L., and Glabe, C.G., Loss of Endosomal/Lysosomal Membrane Impermeability Is an Early Event in Amyloid Abeta1-42 Pathogenesis, J. Neurosci. Res.,1998, vol. 52, pp. 691–698.
Yang, J., Liu, X., Bhalla, K., Kim, C.N., Ibrado, A.M., Cai, J., Peng, T.I., Jones, D.P., and Wang, X., Prevention of Apoptosis by Bcl-2: Release of Cytochrome cfrom Mitochondria Blocked, Science, 1997, vol. 275, pp. 1129–1132.
Yee, W.M., Frim, D.M., and Isacson, O., Relationships between Stress Protein Induction and NMDA-Mediated Neuronal Death in the Entorhinal Cortex, Exp. Brain Res., 1993, vol. 94, pp. 193–202.
Yoo, C.G., Lee, S., Lee, C.T., Kim, Y.W., Han, S.K., and Shim, Y.S., Anti-inflammatory Effect of Heat Shock Protein Induction Is Related to Stabilization of I Kappa B Alpha through Preventing I Kappa B Kinase Activation in Respiratory Epithelial Cells, J. Immunol.,2000, vol. 164, pp. 5416–5423.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Manukhina, E.B., Wiegant, F., Torshin, V.I. et al. Prospects of Non-drug Approaches to Alzheimer's Disease. Biology Bulletin 31, 382–395 (2004). https://doi.org/10.1023/B:BIBU.0000036943.66185.50
Issue Date:
DOI: https://doi.org/10.1023/B:BIBU.0000036943.66185.50